Neonatal hearing screening combined with deafness susceptibility genes testing

Chang LIU,Yan ZHANG,Jie YANG,Hong-ke DING,Chuan NIE,Yu-kun ZENG,Ling LIU,Ai-hua YIN

DOI: https://doi.org/10.13507/j.issn.1674-3474.2017.09.016

2017-01-01

Abstract:Objective To investigate the clinical application of neonatal hearing screening combined with deafness susceptibility genes testing.Methods A total of 5 601 neonates received initial hearing screening by automated auditory brainstem response (AABR) by day 3 to 5 after birth,and otoacoustic emissions (OAE) + AABR test were performed by 42 d after birth in those failing the initial screening.Meanwhile,all neonates were extracted DNA by day 7 after birth for deafness susceptibility genes testing including GJB2,GJB3,SLC26A4 and mtDNA12S rRNA testing.According to the results of the combined detection,all participating families were followed up and provided counselling.Results In 5 601 neonates,5 119 passed the initial hearing screening,and 482 failed.Fifty-four neonates failed the OAE + AABR test and were evaluated by audiology at 3 months old,in which 13 were diagnosed as hearing impairment.In 193 neonates with deafness susceptibility genes mutations,heterozygous mutations with autosomal recessive inheritance were found in 186 neonates (GJB2 gene mutations in 117 neonates,SLC26A4 gene mutations in 62,and GIB3 gene mutations in 7),and mitochondrial DNA 12S rRNA mutations were found in 7 neonates.In 5 601 neonates,15 neonates failed both hearing screening and genetic testing,178 passed hearing screening and failed genetic testing,and 5 369 passed both hearing screening and genetic testing.In 178 neonates failing genetic testing and passing hearing screening,4 developed late-onset deafness,7 were highly sensitive to aminoglycoside ototoxicity,and 167 carried heterozygous mutated genes associated with autosomal recessive deafness.Another 39 neonates failing hearing screening and passing genetic testing received audiology evaluation and further genetic testing,identifying 7 carriers of deafness gene mutations.Conclusion The combined detection of hearing screening and genetic testing enlarges the ranges of attention and intervention in high-risk deafness neonates,and could be of importance in the early diagnosis and therapy.